The results of the Solidarity trial conducted on 11,266 hospitalised patients in 30 countries found remdesivir, along with three other repurposed drugs hydroxychloroquine, lopinavir/ritonavir and interferon to have little or no effect on 28-day mortality.WHO Solidarity trial finds Remdesivir has no substantial effect on mortality in COVID-19 patients
The results of the Solidarity trial conducted on 11,266 hospitalised patients in 30 countries found remdesivir, along with three other repurposed drugs hydroxychloroquine, lopinavir/ritonavir and interferon to have little or no effect on 28-day mortality.
Subscribe to:
Post Comments (Atom)
-
The company, one of the leading manufacturers of soda ash, had initiated the process of carving out its textiles business into GHCL Textile...
-
The BRLLR linked to RBI Repo Rate is revised downwards in line with the reduction on Reserve Bank of India Repo Rate from 5.15 percent to 4...
-
The company did not export units last month while it had dispatched 804 Etios units in in June 2019.
No comments:
Post a Comment